chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a contactable Other Healthcare Professional via Pfizer sales representative. An 89-year-old female patient received PREVNAR 13, via an unspecified route of administration on an unspecified date in 2018 at single dose for immunisation. The patient's medical history and medications were not reported. The patient previously took pneumococcal polysaccharide vaccine, 23-valent (PPSV23) for immunization in 2017. It was reported that the patient was given pneumococcal 13-val conj vac (dipht crm197 protein) 1 year following dose of pneumococcal polysaccharide vaccine, 23-valent, and experienced bruise on upper arm (From shoulder down to elbow) in 2018. The outcome of the event was unknown. No follow-up attempts are Possible. No further information is expected.
Passed Out; Suspecting Seizures pending EEG Results; Sore Arm; This spontaneous case was reported by a pharmacist and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed Out) and SEIZURE (Suspecting Seizures pending EEG Results) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (medication history was not reported) and Pacemaker insertion (cardiac) since an unknown date.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE PAIN (Sore Arm). On 13-Apr-2021, the patient experienced LOSS OF CONSCIOUSNESS (Passed Out) (seriousness criteria hospitalization and medically significant) and SEIZURE (Suspecting Seizures pending EEG Results) (seriousness criterion hospitalization). On 10-Apr-2021, VACCINATION SITE PAIN (Sore Arm) had resolved. At the time of the report, LOSS OF CONSCIOUSNESS (Passed Out) and SEIZURE (Suspecting Seizures pending EEG Results) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not reported. diagnosis yet to be determent Suspecting Seizures pending EEG results  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, Very limited information is available at this time. Further information is requested; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.However, Very limited information is available at this time. Further information is requested.
Patient experienced numbness in left arm (site of administration) on first day, which resolved after 3 days. However, she then experienced numbness and swelling in her left leg/knee. Patient was seen in urgent care and then referred to emergency room and patient was given medication for swelling/fluids, which has resolved after treatment. Patient reported all symptoms have resolved.
Head aches, body aches, low grade fever, sore throat, and swelling, itching and warming of injection site.
Headache, chills, body aches, vomiting, fever, sweating.  Alternating between Tylenol and ibuprofen around the clock. Medication didn?t help much but started feeling better 9/12/21
7 days p/vax 8FEB96 pt adm to hosp w/lethargy & dec tone;required spinal tap to r/o encephalitis, sz disorder r/o;poss gastroenteritis @ time;
This spontaneous report as received from a consumer refers to a 62 year old female patient. The patient did not have a pertinent medical history or drug reactions or allergies. On an unknown date the patient was vaccinated with ZOSTAVAX, .65 ml, subcutaneous. There was no concomitant medication. On approximately 26-MAR-2014 (reported as "about three weeks ago"), the patient's arm began to swell and turned bright red. On approximately 09-APR-2014 (reported as "about a week ago"), the patient also began to develop muscle pain and stiffness in her lower back that was worse in the morning than in the evening. Therefore, the patient could no longer sit for long periods of time in the same manner she was able to before receiving the ZOSTAVAX vaccine. The patient did not seek medical attention and used aspirin and hot showers to help remedy the pain. No lab diagnostic studies were performed. The outcome of the events were reported as not recovered/resolved. No further adverse event information was provided. Additional information has been requested.
School nurse phoned mother and stated child's L arm was red, swollen, sore and hot to touch. Mother then phoned CDC.
Within a week after getting Shingrix, patient complained of a rash and hives across her abdomen and arms.  She took some Benadryl. Patient states that her rash eventually improved but still present.  On 1/14/22 she visited Dr. with the same symptoms and he prescribed her Benadryl 25 mg.
fingers numb lasting a few seconds with arm pain for  5 minutes Narrative:  Other Relevant History:
flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not reported. Concomitant medications were not reported.
Hospitalized 1/1/2022; COVID-19 positive 12/31/2021; fully vaccinated  Admit Date: 1/1/2022  3:23 AM Discharge Date: 1/7/2022  4:31 PM    Hospital Course: Patient is a 50 year old male with history of hypertension, hyperlipidemia, CKD 4, morbid obesity, uncontrolled diabetes, obstructive sleep apnea noncompliant with CPAP, diabetic neuropathy, hypothyroidism presented to the ER with complaints of cough and fever. Patient also had nasal congestion but cough/SOB were at baseline. He was vaccinated for COVID but did nto yet receive booster. In the ER, he tested postive for COVID. CXR showed bilateral airspace disease consistent with COVID pneumonia. Patient was admitted for acute hypoxic respiratory failure due to COVID pneumonia.  Patient was placed on supplemental oxygen and oral dexamethasone.  Oxygen was gradually weaned off to room air at the time of discharge.  Patient continued to have drop in oxygen saturations overnight.  Refused to wear CPAP in the hospital.  Patient prefers following up with his PCP for sleep study referral.   Patient has uncontrolled diabetes which his outpatient endocrinologists have struggled with getting tight control with U500 insulin. Patient had significant hyperglycemia with steroids so DGMS was consulted. HbA1C is 8.3%. IV insulin was recommended, however patient refused it.  Patient's blood sugars slowly improved.   Nephrology was consulted for worsening renal function.  Patient briefly received IV fluids with improvement in renal function.  Lasix was held.  As patient is having good diuresis Lasix was resumed at half the home dose.   Patient was discharged to Home with services - COVID at home in stable condition.
Pt. rec'd Zostavax and vitamin B12 on 8/11/08. one day later had fever, headache, nausea, vomitting and diarrhea. one week later, while vomitting and having diarrhea she had a syncopal episode and woke up 2 hours later. the following day she came to the ER and was admitted. Treatments included; IV hydration, throat culture, nasal spray. 8/21/08-records received for DOS 8/19-8/20/08- DC DX: Syncopal episode. Rhinosinusitis. Presented with 1 week history of URI symptoms and 1 day history of nausea and vomiting which ended in a syncopal episode right after vomiting. Diarrhea. Syncopal episode attributed to vasovagal for bm episode. Throat pain. Admitted for observation.
Information has been received from a physician and a nurse concerning a 10 weeks old female patient with a possible "reflux issue" prior to oral vaccination who on 08-JAN-2009 was orally vaccinated with the first dose of ROTATEQ (660290/0143X). Concomitant therapy included PREVNAR, PENTACEL and RECOMBIVAX HB. It was unknown whether these vaccines were given on the same day. On 11-JAN-2009 the patient's parents reported that she was having loose stool. The patient was brought to the physician's office on 12-Jan-2009. The physician stated that the patient had a "greenish stool with black flakes and mucous smear". The nurse also reported that the patient had been crying and that the "hemoccult test came out mildly positive but the stool culture came back for rotavirus". Upon internal review hematochezia was considered to be another important medical event. Additional information has been requested.
pt recv vax 12JUN95 & 2 hr later devel generalized CNS irritability, inconsolable crying, vomiting; no fever; improved in < 24 hr;
Employee here for COVID vaccine reaction. Vaccine given on 12/28/20 in the posterior left arm below deltoid area and in SUBQ tissue. Employee states area was red around site for 2-3 days area worsened 01/06/21. Area is red, itching, swollen, warm to the touch. Area measures 12 X 8.5cm extending down the arm towards elbow. Has used cortisone cream for the itching. Explained conservative measures with employee including continuing cortisone cream, cool compress, if allowed by PCP using OTC IBU and OTC antihistamines. Explained to continue monitoring site if reaction worsens skin becomes taught or streaking develops to seek further care with PCP or walk in clinic. Employee verbalizes understanding and agrees with plan.
Right arm swelling et itching-started 11/19/14. Tx-BENADRYL et warm compress.
Patient is 17yrs old and Vaccine was given  to her in error.  She came for her second shot  today and we notified patient and parent about this error.  We called CDC and Vaers about this issue and were advised to file this report.
Medical assist preparing more than one patient's vaccinations at the same time. All vaccines were lying on same desk near one another. Medical assistant picked up high dose influenza and gave to the wrong patient in error. PCP notified and error discussed with patient's mother.
My armpit lymph nodes are swollen and very tender on the same arm that my shot was given. my symptoms are not reproducible other than to palpation. There is also visible swelling. no rash or redness in the area.
On the evening of the shot developed pain in my arm, fever and redness. This continue for 2 days, then developed a fever. The fever was on and off for 1 week. The arm became warm and then hot and painful during this first. Took advil and used ice, but barely helped.  Week 2 the pain continue, arm was not warm and very painful.  Week 3 the pain continue, arm was warm and occasionally painful  Week 4 the symptoms began to reduce and by the end of the week 4 was beginning to feel better
Information has been received from a health professional concerning a patient who was vaccinated with a dose of varicella virus vaccine  live (Oka/Merck). Subsequently the patient's IGG levels came back negative. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Pt stated: 7/10 pain in entire right shoulder and down her arm. Tingling and numbness in her fingers (pinky, ring, and middle finger.
The patient did not receive the Pfizer Covid Vaccine as his first doses. The patient received the Janssen Vaccine on 03May2021; The patient did not receive the Pfizer Covid Vaccine as his first doses. The patient received the Janssen Vaccine on 03May2021; booster; The vaccine should have been discarded on 15Jan2022.; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A 67 year-old male patient received bnt162b2 (COMIRNATY), administration date 17Jan2022 (Lot number: FE3594, Expiration Date: Feb2022) at the age of 67 years as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Janssen vaccine (First Dose, Lot Number: 204A21A), administration date: 03May2021, when the patient was 66 years old, for COVID-19 immunization. The following information was reported: OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious), outcome "unknown" and all described as "The patient did not receive the Pfizer Covid Vaccine as his first doses. The patient received the Janssen Vaccine on 03May2021"; IMMUNISATION (non-serious) with onset 17Jan2022, outcome "unknown", described as "booster"; POOR QUALITY PRODUCT ADMINISTERED (non-serious) with onset 17Jan2022, outcome "unknown", described as "The vaccine should have been discarded on 15Jan2022.".  Additional information: Clinical course: It was reported that patient who was administered a booster dose of the Pfizer-BioNTech COVID 19-vaccine (purple cap) on 17Jan2022. The vaccine should have been discarded on 14Jan2022. They pulled up their vaccines for today and administered one of them. They then realized it was supposed to have been discarded after the 14Jan2022. States they need to know what to do. Reporter asks if any additional stability information. The patient did not receive the Pfizer Covid Vaccine as his first doses. The patient received the Janssen Vaccine on 03May2021.  No follow-up attempts are possible. No further information is expected.
Symptoms started day 2- Shaking chills, aches, left arm swelling with redness/rash?/cellulitis? extending down upper arm toward elbow, tender to touch  Contacted Employee Health Office this am 2/8/21 for follow-up. Will follow their recommendations
Thinks son received 2 different vaccines from different manufacturer; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Apr-2021 and was forwarded to Moderna on 02-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Thinks son received 2 different vaccines from different manufacturer) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A or 030M201A and 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Thinks son received 2 different vaccines from different manufacturer). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Thinks son received 2 different vaccines from different manufacturer) had resolved.            Additional information: She is concerned that her son received two different vaccines from different companies such as 1 from Pfizer and 1 Moderna. She wants to verify if this is the case based on the information she has. Dose 1: Left arm, Expiration: 21Aug2021; Dose 2: 23Mar2021, Lot#: 044A21A, Expiration: 31Aug2021, Right Arm vaccinated.
Breakthrough case admission after 5 vaccines Pfizer 2/12/21 Lot# El9267;  Pfizer 3/5/21 Lot# EN6206;  Moderna 10/29/21 Lot# 052#;  Moderna 4/13/22 Lot# 001M21A; Pfizer 9/12/22 Lot# GH9694
About 2 minutes I blacked out and blood pressure went down. I got very cold and chilled. Once I came back around my hands started tingling and started sweating.
Headache, Fatigue, Body Aches, Chills, Shakes, Temp 100.6 also diagnosed with  Bells Palsy after seeing PCP on Monday 01/11/2021. Patient also went back to see PCP on 01/12/2021 for follow up.
Headache and swollen glands. Also sore neck and shoulders on 11/11/02. On 11/13/02, glands were less swollen. Treatment: Advil 300mg po Q6H PRN.
The day after I received the MGC (MCV4) vaccine, I noticed 3 large lumps on my right arm at the injection site, similar to mosquito bites, accompanied by moderate to severe itching. I moved on 6/13/2006, the day after the shot was given. That night, I took some of my Allegra-D because of contact with my aunt's cat and the pollen outside. The 3 "mosquito bites" were now surrounded by a large, raised, red circle measuring 2 inches in diameter with a painful itching and burning sensation. The "mosquito bites" were later recognized to be hives from a local allergic rxn to the vaccine according to the nurse I spoke with on 6/14/2006. She stated that the redness and swelling would go away, and to just keep taking my Allegra-D, icing the spot down, and rubbing cortizone cream on it.   I read the information sheet given to me after the vaccine, which contained this website address, stating that 1/2 of the people who receive this shot experience mild side effects, and then listing the severe side effects. I noticed the only "severe" allergic rxn included the hives and weakness in the right arm where the shot was given. I could not tell if the other symptoms were only from being travel weary and adjusting to the climate change, or other signs of severe allergic rxn. I didn't feel it was necessary to go to an emergency room, however I thought this information should be included about possible local allergic reactions in the information given out about the vaccine so if they have the same problem as I do (it's going away very, very slowly now) they don't become as upset and worried as I was when this started happening.
Morgellons disease; lost my hair; cannot sleep; balance off; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (003110). The reporter is the patient.  A 62-year-old patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: DELUSION OF PARASITOSIS (medically significant), outcome "unknown", described as "Morgellons disease"; ALOPECIA (non-serious), outcome "unknown", described as "lost my hair"; INSOMNIA (non-serious), outcome "unknown", described as "cannot sleep"; BALANCE DISORDER (non-serious), outcome "unknown", described as "balance off". The patient got the second vaccine from Pfizer and had been so sick since. The patient had Morgellons disease, lost hair, cannot sleep, balance off, out or work he/she was in senior health care and # disability has not paid. The patient stated he/she was 62 soon to be 63 super healthy and this was awful.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Vaginal bleeding occurred the morning after injection. LMP 1/5/22. Normal cycle is about 40 days.
Injection given and area puffed out quickly per MA report. Cold pack placed on area and patient asked to wait. A few minutes later triage RN checked w/ patient, visualized area, discussed home care instruction and released patient to home. Mild swelling, slight discoloration, mild pain. No redness, no SOB. Symptoms improving per patient report. Following day patient reported arm fine and symptoms resolved.
Moderna 3/4/21, 4/1/21. Pfizer 11/30/21. Positive on 6/13/22
Very stiff and joint pain.  Pain pills.  I am very stiff to date.  Took pain pills.
Case number PHEH2013US026647 is an initial spontaneous report from a pharmacist received on 30 Dec 2013. This report refers to a 41-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with 0.5ml of FLUVIRIN (batch number: 13452P, expiry date: May 2014) intramuscularly on 11 Dec 2013. The pharmacist reported that the FLUVIRIN which had undergone excursion at 51F for 9 hours has been administered to the patient. No adverse event was reported following this medication error. No additional information was available.
A rash formed, around the injection site, it grew to the point of covering the entire surface of the upper arm. The rash was warm to touch, tender, and itchy. The rash lasted approximately a week, then resolved on its own.
Client anxious prior to immunizations-held mom's hand held her breath. When shots completed she briefly slumped in the chair.  She was responsive when staff raised her head up while in the chair.  T-97.2, P-73, BP 142/72. Recheck 130/80.  O2Sats 99%.  Recommended that she go to the ER if any other concerns arise 10/10/2023-F/U call to father of who reports that she is fine and that he felt that she had a panic attack about getting the vaccines.
Have become extremely sick and nauseous and weak, exactly 1 week following vaccination. Constantly throwing up for almost 12 hours as well as being unable to walk or sit up without almost passing out. Stuck in bed for almost 3 days.
3 bowel movements in 8 hours; Unfocused Mind; This is a spontaneous report received from a contactable consumer, the patient. A 57-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in right arm on 20Mar2021 at 09:15 (at the age of 57-years) as a single dose for COVID-19 immunisation. Medical history included obesity, renal insufficiency and fatty liver. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021 at 09:45 (35 minutes after injection), the patient had unfocused mind (easily lost his train of thought) for the duration of 6 hours. On 21Mar2021 (day after injection), the patient was ok in the morning and then had 3 bowel movements in 8 hours. The patient did not experience diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for these events. The clinical outcome of the event unfocused mind was recovered on 21Mar2021 and outcome of the event 3 bowel movements in 8 hours was unknown at the time of this report.   No follow-up attempts are needed. No further information was expected.